Tilray Brands, Inc. (TLRY) Financials
TLRY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Aug. 31, 2026 | 2.3 billion | 721.3 million |
| May 31, 2026 | 2.3 billion | 733.1 million |
| Feb. 28, 2026 | 2.1 billion | 549.1 million |
| Nov. 30, 2025 | 2.9 billion | 771.3 million |
TLRY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Aug. 31, 2026 | -27.6 million | 6.6 million |
| May 31, 2026 | -47.7 million | 14.9 million |
| Feb. 28, 2026 | -26.0 million | 13.7 million |
| Nov. 30, 2025 | -25.5 million | 17.2 million |
TLRY Net Income
No data available :(
TLRY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Aug. 31, 2026 | 218.0 million | 118.0 million | 158.6 million |
| May 31, 2026 | 231.3 million | 200.0 million | 158.2 million |
| Feb. 28, 2026 | 219.9 million | 223.3 million | 67.5 million |
| Nov. 30, 2025 | 407.3 million | 314.3 million | 96.6 million |
TLRY Shares Outstanding
TLRY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Aug. 31, 2026 | 11.0 million | 89000 | 86.9 million | 29.3 million |
| May 31, 2026 | 10.2 million | 180000 | 88.6 million | 27.5 million |
| Feb. 28, 2026 | 3.9 million | 62000 | 69.5 million | 19.3 million |
| Nov. 30, 2025 | 13.5 million | 78000 | 72.9 million | 21.8 million |
TLRY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Aug. 31, 2026 | 257.1 million | 179.6 million |
| May 31, 2026 | 281.7 million | 197.4 million |
| Feb. 28, 2026 | 206.7 million | 151.8 million |
| Nov. 30, 2025 | 217.5 million | 160.0 million |
TLRY Revenue by Segment
Graph available only for paid members. Upgrade to see it.
TLRY
Price: $2.53
52 week price:
Earnings Per Share: -1.41 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 12.7 million
Market Capitalization: 483.3 million